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Abstract In this paper the association between smoking
history, beverage consumption, diet and bladder cancer
incidence is systematically reviewed. A rating system has
been used to summarise the level of scientiﬁc evidence
(i.e. convincing, probable, possible, and no evidence)
and the level of association (i.e. substantially increased,
(RR‡2.5), moderately increased (1.5 £ RR<2.5),
slightly increased (1.2 £ RR<1.5), no association
(0.8 £ RR<1.2), slightly decreased (0.7 £ RR<0.8),
moderately decreased (0.4 £ RR<0.7), and sub-
stantially decreased (RR<0.4)). There is convincing
evidence that cigarette smoking status, frequency and
duration substantially increase the risk of bladder can-
cer. However, the evidence is not clear for other forms of
smoking. A small increased risk for cigar, pipe, and
environmental smoking is only possible. There is possi-
ble evidence that total ﬂuid intake is not associated with
bladder cancer. Although there is convincing evidence
for a positive association between alcohol consumption
and bladder cancer risk in men, the risk is small and not
clinically relevant. Coﬀee and tea consumption are
probably not associated with bladder cancer. The au-
thors conclude that total fruit consumption is probably
associated with a small decrease in risk. There is prob-
ably no association between total vegetable intake,
vitamin A intake, vitamin C intake and bladder cancer
and a possibly moderate inverse association with vita-
min E intake. Folate is possibly not associated with
bladder cancer. There probably is a moderate inverse
association between selenium intake and bladder cancer
risk.
Keywords Smoking Æ Nutrition Æ Diet Æ Bladder
neoplasms Æ Review Æ Epidemiology
Bladder cancer is the most common cancer of the urinary
tract and is the ninth most common cancer among men,
accounting for approximately 330,000 new cases and
130,000 deaths per year worldwide [1]. In the United
States, the Netherlands and Belgium, bladder cancer is
rated among the top ﬁve ofmost frequent cancers inmales
[1, 2, 3]. Bladder cancer is considerably more common in
men than in women, but still approximately 60,000
women are diagnosed with the disease every year world-
wide [1]. Like many solid tumours, bladder cancer inci-
dence increases with age. Tumours of the bladder rarely
occur before the age of 40–50, arising most commonly in
the seventh decade of life [3]. The incidence of bladder
cancer varies considerably among countries [3, 4]. In
general, the highest incidence rates for bladder cancer are
found in the developed countries of Western Europe,
North America and Australia; relatively low rates are
found in the Far Eastern countries [1]. Since the world
population is increasing and given the ageing population
in the world, the incidence of bladder cancer will probably
increase in the next decades. Therefore, prevention of
bladder cancer, just as other forms of cancer, should
continue to be of public interest.
About 90% of bladder cancers are transitional cell
carcinomas, cancers that begin in the urothelial cell lining.
About 80% of bladder tumours are conﬁned to the
bladder mucosa, the so-called superﬁcial tumours, and
20% invade themuscle layer [5]. Haematuria, pain during
urination and frequent urination are the most common
symptoms of both types of cancer [6, 7]. However, the
management and prognosis of these cancers are com-
pletely diﬀerent: superﬁcial tumours are fairly benign, and
invasive tumours are highly malignant. Depending on its
stage and grade, bladder cancer may be treated with sur-
gery, radiation therapy, (local) chemotherapy, or (local)
immunotherapy.
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Along with lung cancer, bladder cancer was one of the
earliest cancers to undergo serious epidemiologic inves-
tigation. As a consequence, some important causes of
bladder cancer such as cigarette smoking, occupational
exposure, and chronic infections with schistosoma hae-
matobium have been known for decades. At present,
evidence on dietary factors is also accumulating. The re-
cent controversy concerning the inﬂuence of ﬂuid con-
sumption and diet on the risk of bladder cancer points to
some of the still unanswered questions about the aetiology
of the disease. Avoidance of hazardous behaviour (e.g. by
means of health education and promotion) is possibly one
of the most eﬀective strategies in bladder cancer preven-
tion. In this paper we evaluate three behavioural factors
that are potentially associated with bladder cancer risk:
smoking, beverage consumption, and diet.
Data sources
Primary epidemiologic studies were identiﬁed
through computerised database searches for systematic
reviews, follow-up studies, case-control studies, ecologi-
cal studies and controlled trials published from 1966 to
August 2003 and through reference checking [8]. We
systematically reviewed the eﬀects of smoking, beverage
consumption, and diet and summarised their association
with bladder cancer in levels of evidence and levels of
association based on the results of previous literature and
speciﬁcally on the ongoing Netherlands Cohort Study on
diet and cancer (NLCS). The NLCS is the largest pro-
spective cohort study to date conducted to investigate risk
factors of bladder cancer.
The NLCS was initiated in 1986 with 120,852 men and
women aged 55–69 years [9]. The subjects originated from
204 municipal population registries throughout the
country. Data regarding potential risk factors for cancer
were collected by means of a self-administered question-
naire. Follow-up for incident bladder cancer was estab-
lished by record linkage to all regional cancer registries in
The Netherlands and with the national pathology register
(PALGA) [10]. For eﬃciency purposes, the case cohort
approach was used for data processing and analysis [11,
12]. Following this approach, a subcohort of 3,500 sub-
jects (1,688 men and 1,812 women) was randomly sam-
pled from the cohort after the baseline exposure
measurement. During a follow-up period of 6.3 years
(September 1986–December 1992), 619 incident bladder
cancer cases were detected. To date, six papers from the
NLCS have described the associations between smoking,
beverage consumption, diet [13, 14, 15, 16, 17, 18] and
bladder cancer.
Levels of evidence and levels of association
A rating system, adapted from the World Cancer Re-
search Fund [19], has been used to summarise the level of
scientiﬁc evidence for these risk factors; it consists of four
levels: convincing, probable, possible, and no evidence.
The rating has been based on the number of epidemiologic
studies showing consistent associations and whether or
not supportive mechanistic evidence is present (Table 1).
The level of association across cohort studies is
categorised as substantially increased risk (RR‡2.5),
moderately increased risk (1.5 £ RR<2.5), slightly
(or small) increased risk (1.2 £ RR<1.5), no associ-
ation (0.8 £ RR<1.2), slightly (or small) decreased risk
(0.7 £ RR<0.8), moderately decreased risk (0.4 £
RR<0.7), and substantially decreased risk (RR<0.4).
The level of association is estimated based on the previous
results of case-control and cohort studies. Apart from
previously published meta-analyses, the results were not
further statistically pooled because too much hetero-
geneity in populations, designs, and eﬀect measures oc-
curred between the studies. We constructed a matrix in
which the levels of evidence were combined with the levels
of association (Table 2).
For each risk factor with probable or convincing evi-
dence for a moderately or substantially altered bladder
cancer risk, the etiologic fraction was calculated based on
the level of association and the prevalence of exposure in
the subcohort of the NLCS. The subcohort serves as a
representative sample (n=3,500) of the Dutch adult
population [9]. The etiologic fraction—or population
attributable risk—is the proportion of the bladder cancer
cases for which a speciﬁc exposure contributed to the
disease aetiology [20].
Cigarette, cigar, pipe, and environmental smoking
We will only brieﬂy outline the impact of cigarette, cigar,
pipe, and environmental smoking because this is also
reported by Sommer et al. [20a].
Previous epidemiologic studies
Cigarette smoking
During the last four decades, many epidemiologic
studies [21, 22, 23, 24] and reviews [19, 25, 26, 27, 28, 29,
30, 31, 32, 33] have consistently shown that cigarette
smoking substantially increases the risk of bladder
cancer. In a recent meta-analysis of 43 published case-
control and cohort studies, we estimated that current
Table 1 Levels of evidence for etiological risk factors for disease
Number of epidemiologic
studies showing consistent
associations (Nstudy)
Supportive
mechanistic
evidencea
No supportive
mechanistic
evidenceb
Nstudy‡15 Convincing Probable
5 £ Nstudy<15 Probable Possible
1 £ Nstudy<5 Possible Possible
Nstudy=0 No evidence No evidence
aBiologically plausible and supportive laboratory evidence
bBiologically not plausible or no supportive laboratory evidence
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cigarette smokers have an approximately threefold
higher risk of bladder cancer than non-smokers [21]. The
age- and gender-adjusted summary odds ratios for cur-
rent and former cigarette smokers compared with those
for nonsmokers were 3.33 (95% conﬁdence interval
[95% CI], 2.63–4.21) and 1.98 (95% CI 1.72–2.29),
respectively. A positive dose-response relationship has
been found with both the number of cigarettes smoked
per day and the number of years smoked. Age at ﬁrst
exposure and cessation of cigarette smoking were in-
versely associated with bladder cancer risk [21].
Cigar, pipe, and environmental smoking
The evidence of an association between bladder cancer
risk and cigar [34, 35, 36, 37, 38, 39] and pipe [34, 35, 36,
37, 38, 39, 40] smoking is not often reported (n=7 and 8,
respectively), inconsistent, and generally weaker than
the association with cigarette smoking [25, 27, 31, 33].
Only two case-control studies investigated the associa-
tion between environmental smoking and bladder cancer
risk [35, 41]. These studies have reported small increased
risks for those exposed to environmental smoking
compared with those not exposed to environmental
smoking (0.6 £ RR<1.6).
Netherlands cohort study
Cigarette smoking
In the Netherlands Cohort Study these associations were
investigated in more detail [18]. From this study we con-
cluded that the above-mentioned associations of cigarette
smoking characteristics with bladder cancer risk were
largely attributable to cigarette smoking duration and
that these associations were independent of diﬀerences in
tumour invasiveness or morphology. Furthermore, the
tar and nicotine content of cigarettes, and ﬁlter-tip usage
were only weakly associated with bladder cancer risk.
Cigarette smoking cessation and age at ﬁrst exposurewere
not associated with bladder cancer risk after taking into
account the total smoking duration [18]. These results
were comparable with the overall results from the meta-
analysis [21] and the pooled analyses [22, 23].
Cigar, pipe, and environmental smoking
We conﬁrmed a substantially increased risk of bladder
cancer for current cigar (RR 2.88, 95% 1.68–4.93) and
pipe smokers (RR 3.03, 95% 1.67–5.50) versus those
who never smoke tobacco; however, these risks were
confounded by cigarette smoking and disappeared after
adjustment for cigarette smoking [18].
Mechanistic evidence
Cigarette smoking
The precise mechanism by which cigarette smoking
causes bladder cancer has yet to be determined. It
seems most likely that the risk of bladder cancer is
related to some of the large number of chemicals
present in smoke. 2-Naphthylamine and 4-aminobi-
phenyl are the leading candidates as the speciﬁc etio-
logic agents [27, 32, 33, 42, 43]. Besides the eﬀect that
many compounds in cigarettes can cause carcinogenic
events in the bladder, cigarette smoking has been found
to increase proliferation, as evidenced by hyperplasia of
the bladder epithelium [33].
Cigar, pipe, and environmental smoking
An association between cigar and pipe smoking and the
risk of bladder cancer is biologically plausible since
the smoke of both types of tobacco contains many of the
Table 2 Levels of evidence and levels of association for risk factors (exposed vs. not exposed) for urinary bladder cancer
Evidence Convincing1 Probable2 Possible3
Substantially increased riska Cigarette smoking - -
Moderately increased riskb - - -
Slightly increased riskc Alcohol consumption* - Cigar smoking
Pipe smoking
Environmental smoking
No associationd - Coﬀee consumption Total ﬂuid consumption
Tea consumption Folate intake
Vegetable consumption
Vitamin A intake**
Vitamin C intake
Slightly decreased riske - Fruit consumption -
Moderately Decreased riskf - Selenium intake Vitamin E intake
Substantially decreased riskg - - -
1Convincing: ‡15 well designed epidemiologic studies showing
consistent associations (Nstudy) and supportive mechanistic evi-
dence, 2Probable: 5 £ Nstudy<15 and supportive mechanistic evi-
dence, or Nstudy‡15 and no supportive mechanistic evidence.
3Possible: 5 £ Nstudy<15 and supportive mechanistic evidence, or
1 £ Nstudy<5
a(RR‡2.5), b(1.5 £ RR<2.5), c(1.2 £ RR<1.5), d(0.8 £ RR<
1.2), e(0.7 £ RR<0.8), f(0.4 £ RR<0.7), g(RR<0.4), comparing
exposure vs. no exposure
*for men; the risk related to alcohol consumption for women
remains unclear,
**and carotenoids
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same substances as present in cigarette tobacco. How-
ever, cigar and pipe smokers inhale less than cigarette
smokers, which might explain an increased cancer inci-
dence for cigar and pipe smokers in local areas of the
human body (e.g. head/neck cancer) and no increased
risk through a systemic eﬀect (e.g. bladder cancer). Data
from experimental studies also support the hypothesis
that non-smokers might be exposed to potential car-
cinogens through the cigarette smoke of others [44].
Mutagens have been detected in the blood and urine
of passive smokers [44, 45].
Conclusions
Judging the evidence, we conclude that there is con-
vincing evidence from many epidemiologic and mecha-
nistic studies that cigarette smoking substantially
increases the risk of bladder cancer (Table 2). Although
an association with cigar and pipe smoking could be
mechanistically explained, there is also biologically
plausible evidence for no association with bladder can-
cer risk. The results from many epidemiologic studies
concerning cigar and pipe smoking are not consistent.
We therefore conclude that a small increased risk for
cigar and pipe smoking is only possible. An increased
risk through exposure to environmental smoking is
supported by mechanistic evidence, although more epi-
demiologic studies are needed to conﬁrm this. A small
association between exposure to environmental smoking
and bladder cancer risk possibly exists (Table 2).
Etiologic Fraction
Since there is convincing evidence for a substantially
increased risk of bladder cancer for cigarette smokers,
the etiologic fraction of cigarette smoking was calcu-
lated. Cigarette smoking accounts for 23% of all female
bladder cancer, whereas in men 50% of the disease is
attributable to cigarette smoking.
Total fluid, alcohol, coffee, and tea consumption
Previous epidemiologic studies
Total ﬂuid consumption
Previous case-control and cohort studies on total ﬂuid
consumption and bladder cancer risk have shown
inconsistent results. Seven case-control studies reported
positive associations (1.4 £ RR37, 46, 47, 48, 49, 50],
whereas three other case-control studies found no
association (0.8 £ RR51, 52, 53]. Only one case-control
study reported an inverse association between total ﬂuid
consumption and bladder cancer risk in women, but not
in men [57]. Apart from the Netherlands Cohort Study,
two cohort studies to date were conducted to investigate
this association [55, 56]. One cohort study did not ﬁnd
an association between ﬂuid consumption and bladder
cancer risk [55], whereas the other reported an inverse
association of total ﬂuid consumption (RR=0.5) [56].
Alcohol consumption
Previous studies also have investigated associations of
the consumption of speciﬁc ﬂuids (i.e. alcohol, coﬀee
and tea) with bladder cancer risk. We have concluded,
based on a meta-analysis of 30 epidemiologic studies [57]
that the available data suggest a slightly increased cig-
arette smoking-adjusted risk of bladder cancer from
alcohol consumption for men, which, however, is small
and not statistically signiﬁcant (RR=1.3, CI 0.9–2.0,
comparing any alcohol consumption with no alcohol
consumption) [57]. The risk related to alcohol con-
sumption for women remains unclear [57].
Coﬀee consumption
Narrative reviews on coﬀee consumption and bladder
cancer concluded that the epidemiologic evidence was
consistent with a small positive association, possibly due
to confounding by smoking [19, 31, 58, 59, 60]. Most
conclude that further research is necessary to decide
whether the association is causal or due to confounding
by smoking. In our meta-analysis the available evidence
based on 14 epidemiologic studies suggested a very small
and borderline signiﬁcant increased risk for coﬀee con-
sumers remaining after adjustment for age, cigarette
smoking and sex (RR=1.2, CI 1.0–1.4), although this
was predominantly based on case-control data [57].
Tea consumption
We found in a systematic review based on seven epi-
demiologic studies that current consumption of tea
seems not to be related to an increased risk of bladder
cancer. The summary odds ratio for tea drinking com-
pared with no tea drinking was 1.0 (CI 0.9–1.1) [57].
Netherlands Cohort Study
Total ﬂuid consumption
In the Netherlands Cohort Study the association be-
tween ﬂuid intake and bladder cancer risk was examined
in detail [15, 16]. In this study, neither total ﬂuid con-
sumption nor total water intake were associated with
bladder cancer risk [15].
Alcohol consumption
The positive association between alcohol consumption
and male bladder cancer found in the Netherlands
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Cohort Study was small and independent of diﬀerences
in tumour invasiveness and morphology [16]. We found
no association between alcohol consumption and blad-
der cancer risk for women [16].
Coﬀee consumption
The results of the Netherlands Cohort Study supported
a small positive association between coﬀee consumption
and male bladder cancer, mainly conﬁned to the higher
consumption categories after adjusting for cigarette
smoking [15]. For women, an inverse association was
found [15].
Tea consumption
Tea consumption was inversely associated with bladder
cancer for both men and women in the Netherlands
Cohort Study, irrespective of consumption frequency [15].
Mechanistic evidence
Total ﬂuid consumption
The urogenous-contact hypothesis associates the devel-
opment of bladder cancer with prolonged exposure to
carcinogens in urine [56, 61]. High consumption of ﬂuids
may reduce this exposure by diluting the urine and
reducing contact time through increased frequency of
urination. However, total ﬂuid consumption has also
been hypothesised to increase the risk of bladder cancer
by increasing the workload of the bladder or by exposing
the bladder to speciﬁc ﬂuids that contain carcinogens
[50, 52].
Alcohol consumption
Also, several possible mechanisms to explain carcino-
genesis by alcohol intake have been postulated. Heavy
alcohol consumption may, through its eﬀect on the
liver and hepatic enzyme systems, reduce the detoxiﬁ-
cation of carcinogenic substances [62]. Furthermore,
ethanol slows down protein synthesis. One conse-
quence of this is that cell repair mechanisms might be
inhibited, which could lead to malignant changes [63,
64, 68]. Ethanol might improve the permeability of
membranes to carcinogens and might enhance carcin-
ogenic activity [64, 65, 66]. Other explanations include
the eﬀect of ethanol on cell proliferation, possibly
caused by the ethanol metabolite acetaldehyde [33, 62,
64, 65].
Coﬀee consumption
Caﬀeine and other substances in coﬀee could have direct
or indirect metabolic eﬀects and modify concentrations
of carcinogenic or anticarcinogenic substances in
bladder epithelium [59]. Since most of these substances
or their metabolites are excreted by the bladder, they
have to come into contact with the mucous membrane of
the bladder ﬁrst. However, there are no clear-cut con-
clusions from animal studies on the potential carcino-
genic eﬀects of coﬀee. According to most animal studies,
coﬀee and caﬀeine do not have a carcinogenic eﬀect in
laboratory animals, nor can they induce tumours, or
potentiate or inhibit the carcinogenic eﬀects of other
substances [59]. However, Lopez-Abente et al. have
suggested that caﬀeine may act as an inducer of
CYP1A2 (a cytochrome P450 enzyme), which may be
related to risk of bladder cancer through metabolic
activation of aromatic amines and formation of com-
pounds that in turn lead to formation of DNA adducts
[67]. High consumption of coﬀee (more than four cups
of coﬀee per day) has been observed to lead to such
induction in N-oxidation activity, dependent on
CYP1A2 [67].
Tea consumption
Evidence from animal studies shows that certain
compounds present in tea may have inhibitory eﬀects
on bladder tumour formation and growth. This inhibi-
tory activity is believed to be mainly due to the anti-
oxidative and possibly antiproliferative eﬀects of
polyphenol compounds (e.g. ﬂavonoids) [68, 69, 70, 71,
72]. It has been pointed out that no other agent tested
for possible chemoprevention eﬀects in animal models
has elicited such strong activity as tea and its compo-
nents at concentrations usually consumed by humans
[70].
Conclusions
Although epidemiologic and mechanistic evidence are
not consistent, the weight of evidence is not in favour of
a protective eﬀect of ﬂuid intake. We, therefore, tenta-
tively conclude that it is possible that total ﬂuid intake is
not associated with bladder cancer risk (Table 2). There
is convincing evidence for a small positive association
between alcohol consumption and bladder cancer risk in
men. The risk related to alcohol consumption for wo-
men remains unclear. Most epidemiologic and mecha-
nistic studies were not supportive for an increased
bladder cancer risk for coﬀee consumers. Probably there
is no association between coﬀee consumption and
bladder cancer. If an increased risk exists, it is probably
weak and mainly conﬁned to the higher consumption
categories. Although there is supportive mechanistic
evidence for a negative association between tea con-
sumption and bladder cancer risk, most epidemiologic
studies could not conﬁrm this. We conclude that tea
consumption is probably not associated with the risk of
bladder cancer (Table 2).
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Fruit, vegetable, vitamin (A, C, E and folate),
and selenium intake
Previous epidemiologic studies
Fruit and vegetable consumption
Recently, a meta-analysis on seven case-control studies
and three cohort studies concerning bladder cancer and
fruit consumption reported small elevated smoking-ad-
justed bladder cancer risks among subjects with low fruit
consumption vs. subjects with high fruit consumption
(RR=1.5, CI 1.3–1.7) [73]. The same meta-analysis also
found a small positive smoking-adjusted association
between vegetable consumption and bladder cancer
risk comparing high vs. low consumption (RR=1.2,
CI 1.0–1.4) [73].
Vitamin intake
Furthermore, themeta-analysis did not ﬁnddiﬀerent risks
of bladder cancer in relation with diets low in retinol or b-
carotene compared with diets high in retinol and b-caro-
tene (RR=1.0, CI 0.8–1.2) in seven case-control studies
and three cohort studies [73]. Two other prospective
studies that were published more recently also found no
association between supplemental and dietary vitamin A
intake [74, 75]. The majority of epidemiologic studies on
dietary vitamin C intake reported relative risks around
unity for high vs. low intake [51, 76, 77, 78, 79, 80]. Most
epidemiologic studies reported inverse associations be-
tween supplemental intakes of vitamin E in relation to
bladder cancer risk (0.5 £ RR75, 78, 81]. Dietary vitamin
E intake was also inversely associated with bladder cancer
in one study [76]. The epidemiologic evidence relating
dietary folate and the risk of bladder cancer is limited.One
case-control study found an inverse association with
bladder cancer risk (RR=0.5, comparing highest with
lowest quartiles of intake) [81], whereas one cohort study
did not ﬁnd an association between total folate intake and
bladder cancer incidence [75].
Selenium intake
Apart from the Netherlands Cohort Study, four pro-
spective studies investigated the association between
serum or toenail selenium and bladder cancer risk [82,
83, 84, 85]. Most studies found a moderate inverse
association between selenium status and bladder cancer
risk (0.3 £ RR84].
Netherlands cohort study
Fruit and vegetable consumption
In the Netherlands Cohort Study, an inverse association
was found between bladder cancer risk and fruit con-
sumption (RR=0.7, CI 0.5–1.0, comparing highest vs.
lowest quintile of consumption). This protective eﬀect
was mainly conﬁned to invasive transitional cell carci-
nomas, irrespective of tumour morphology [13]. The
results showed that total vegetable consumption was not
associated with bladder cancer risk (RR=0.9, CI 0.7–
1.3, comparing highest vs. lowest quintile of consump-
tion) [13].
Vitamin intake
We have concluded furthermore that dietary or supple-
mental intake of vitamin A, vitamin C, vitamin E, and
dietary intake from folate and most carotenoids were
not associated with bladder cancer risk [14]. Only the
carotenoid b-cryptoxanthin appeared to be inversely
associated with bladder cancer risk when comparing
highest versus lowest quintiles of intake (RR=0.7, CI
0.5–1.0), which appeared to be independent of diﬀerent
tumour invasiveness and morphology [14]. Citrus fruits
are the main sources of b-cryptoxanthin.
Selenium intake
The results of the Netherlands Cohort Study showed a
moderate inverse association between base-line toenail
selenium and subsequent bladder cancer risk (RR=0.7,
CI 0.5–0.9). The association was most pronounced in
ex-smokers and mainly conﬁned to invasive carcinomas
of the bladder [17].
Mechanistic evidence
Fruit and vegetable consumption
There are many candidate agents in fruit and vegetables
that potentially inﬂuence bladder cancer risk. Some
possible anticarcinogenic mechanisms of substances in
fruits and vegetables include antioxidant eﬀects, eﬀects
on cell diﬀerentiation, increased activity of enzymes that
detoxify carcinogens, blocked formation of nitrosam-
ines, preserved integrity of intracellular matrices, eﬀects
on DNA methylation, maintenance of normal DNA
repair, increased apoptosis of cancer cells and decreased
cell proliferation [86].
Vitamin intake
Retinol is the physiologically active form of vitamin A
and can be derived from some carotenoids. Carotenoids
have antioxidant properties and may inhibit carcino-
genesis by preventing DNA damage induced by free
radicals. Furthermore, vitamin A is important for cell
diﬀerentiation and since lack of diﬀerentiation is a fea-
ture of cancer cells, a protective eﬀect of vitamin A on
cancer development may be expected [87, 88, 89]. Vita-
min C is mostly known for its antioxidant capacity [87]
and its ability to prevent formation of nitrosamine and
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other N-nitroso compounds [90]. Like vitamin C, vita-
min E is an intracellular antioxidant and can inhibit
nitrosation [19, 88, 91]. Furthermore, vitamin E has the
capacity to keep selenium in reduced state [87]. Folate is
essential for methylation reactions in the human body.
Reduced methylation of DNA may contribute to loss of
normal controls on proto-oncogene expression. Folate
deﬁciency causes massive incorporation of uracil into
human DNA and chromosome breaks. Such breaks
could contribute to an increased risk of cancer [92, 93].
Selenium intake
Several hypotheses have been proposed to explain the
inhibition of tumourgenesis by selenium, including
alterations in carcinogen metabolism, eﬀects on the
endocrine and immune systems, production of cytotoxic
selenium metabolites, inhibition of protein synthesis,
inhibition of speciﬁc enzymes, inhibition of tumour
growth, stimulation of apoptosis and protection against
oxidative stress involving the function of selenium
as a constituent in the antioxidant enzyme glutathione
peroxidase [83, 85, 88, 94, 95, 96, 97, 98].
Conclusions
We conclude that high consumption of total fruit is
probably associated with a small decrease in bladder
cancer risk (Table 2). There is probably no association
between total vegetable intake and bladder cancer risk,
although an inﬂuence of speciﬁc vegetables on bladder
cancer risk cannot be excluded. Although the mecha-
nistic evidence is in favour of an inverse association
between vitamin A, carotenoids, vitamin C intake and
subsequent bladder cancer risk, the epidemiologic evi-
dence does not support this. We tentatively conclude
that vitamin A, carotenoids, and vitamin C intake are
probably not associated with bladder cancer risk. Few
epidemiologic studies and mechanistic evidence support
a possibly moderate inverse association between vitamin
E intake and bladder cancer risk. The epidemiologic
evidence for the intake of folate is still limited and
conﬂicting. From a mechanistic point of view, however,
a protecting eﬀect from folate intake is plausible. Until
more epidemiologic studies are conducted, we conclude
that there is possible evidence that folate is not associ-
ated with bladder cancer risk. There probably is a
moderate inverse association between selenium intake
and bladder cancer risk (Table 2).
Etiologic fraction
Since there is probable evidence for a moderately de-
creased risk of bladder cancer for subjects with high
selenium status, the etiologic fraction was calculated
based on the results of the Netherlands Cohort Study. If
toenail selenium status of subjects in the two lowest
quintiles of the Dutch population ( £ 0.530 lg/g) could
be increased to the level of the third quintile (0.530–
£ 0.573 lg/g), approximately 20% less bladder cancer
could be attributable to selenium deﬁciency.
Future research: gene environment
Polymorphism environment
Epidemiology has traditionally evaluated environmental
risk factors such as smoking, beverage consumption, and
diet, which has provided an important contribution to our
knowledge on bladder cancer aetiology. Although ciga-
rette smoking has been identiﬁed as the most important
risk factor for bladder cancer, knowledge of this and other
environmental risk factors and possible pathways alone is
probably not suﬃcient to completely explain the incidence
of bladder cancer. Epidemiologists could extend their
studydesigns to studies designed to evaluate the combined
eﬀect of environmental factors (e.g. cigarette smoking)
and genetic factors. This combinationmight explainmore
variation in bladder cancer incidence than using these
environmental risk factors alone.
For example, N-acetyltransferase 2 (NAT2) or glu-
tathione S-transferase Mu1 (GSTM1) polymorphisms
may modify the metabolism of tobacco carcinogens.
Slow acetylation or lack of GSTM1 activity (which is
present in 50% of Caucasians) might result in a higher
concentration of tobacco carcinogens in the bladder and
consequently enhance the risk of bladder cancer among
cigarette smokers [99, 100, 101]. The enzyme coded by
the gene CYP2D6, debrisoquine hydroxylase, is hy-
pothesised to be involved in the nicotine metabolism.
However, previously conducted studies have not asso-
ciated variation in this genotype with an increased
bladder cancer risk [100, 101, 102]. The enzyme coded by
the CYP1A1 gene (one of the cytochrome P-450 genes),
aryl hydroxylase, may be involved in the meta-
bolic activation of polycyclic arylhydrocarbons [100].
Through further epidemiologic research on polymor-
phism-environment interaction it might become possible
to identify individuals with a higher susceptibility of
bladder cancer after exposure to potential carcinogens
compared with the general population. Such a study is
currently underway in the Belgian province of Limburg
(E Kellen, MP Zeegers, F Buntinx, Bladder cancer in
Limburg: a discovery of determinants through epide-
miological research, submitted for publication).
Mutation environment
Parallel to these new genetic epidemiologic approaches to
understanding bladder cancer aetiology, there have been
important advances in understanding molecular genetics
of bladder cancer, i.e. in identifying the series of somatic
changes in bladder cells that in combination lead to the
development of the malignant phenotype [32]. Genetic
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diﬀerences seem to exist between papillary and non-pap-
illary carcinomas. The high-grade, non-papillary transi-
tional cell carcinoma usually contains a defect in
chromosome 17, which represents an abnormality in the
p53 gene. By contrast, changes in chromosome 9 are
associated with superﬁcial papillary tumours [33]. In the
Netherlands Cohort Study, we have found diﬀerent
associations with some of the investigated risk factors
depending on tumour invasiveness and morphology. It
appeared that a protective eﬀect of toenail selenium level
and fruit consumption was mainly conﬁned to invasive
transitional cell carcinomas, irrespective of tumour mor-
phology [13, 17]. However, associations for cigarette
smoking, andalcohol intakewere independent of diﬀerent
tumour invasiveness andmorphology [16, 18]. It might be
interesting for epidemiologists to investigate associations
between speciﬁc environmental risk factors and speciﬁc
mutations that lead to diﬀerent morphology and inva-
siveness of bladder cancer.
Conclusion
Convincing
Based on the results of previous epidemiologic studies
and mechanistic evidence, we conclude that the most
important risk factor for bladder cancer is cigarette
smoking. Prevention of cigarette smoking would result
in a decrease of 50% of male bladder cancer cases and
23% of female bladder cancer cases. Alcohol con-
sumption is the only other convincing risk factor for
bladder cancer, although previous research suggests that
the risk elevation for alcohol consumers is very small,
which might not be of practical importance (Table 2).
Probable
There is probably no association between coﬀee, tea,
vitamin A and C intake and subsequent bladder cancer
risk and a negative association with fruit consumption
and selenium intake (Table 2).
Possible
It is possible that cigar, pipe and passive smoking
slightly increase bladder cancer risk, that total ﬂuid
consumption and folate intake are not associated with
bladder cancer risk, and that vitamin E intake decreases
bladder cancer risk. Further research is needed to con-
ﬁrm these conclusions (Table 2).
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